Ligands for cannabinoid receptors, promising anticancer agents

Life Sciences
Marjan NikanAzadeh Manayi

Abstract

Cannabinoid compounds are unique to cannabis and provide some interesting biological properties. These compounds along with endocannabinoids, a group of neuromodulator compounds in the body especially in brain, express their effects by activation of G-protein-coupled cannabinoid receptors, CB1 and CB2. There are several physiological properties attributed to the endocannabinoids including pain relief, enhancement of appetite, blood pressure lowering during shock, embryonic development, and blocking of working memory. On the other hand, activation of endocannabinoid system may be suppresses evolution and progression of several types of cancer. According to the results of recent studies, CB receptors are over-expressed in cancer cell lines and application of multiple cannabinoid or cannabis-derived compounds reduce tumor size through decrease of cell proliferation or induction of cell cycle arrest and apoptosis along with desirable effect on decrease of tumor-evoked pain. Therefore, modulation of endocannabinoid system by inhibition of fatty acid amide hydrolase (FAAH), the enzyme, which metabolized endocannabinoids, or application of multiple cannabinoid or cannabis-derived compounds, may be appropriate for the treatment of seve...Continue Reading

References

Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·L De PetrocellisV Di Marzo
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·Z JáraiG Kunos
Jul 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·B F CravattA H Lichtman
Nov 8, 2001·Trends in Pharmacological Sciences·E Schlicker, M Kathmann
May 31, 2002·Pharmacological Reviews·A C HowlettR G Pertwee
Dec 31, 2002·Chemistry and Physics of Lipids·Norbert Hájos, Tamás F Freund
Oct 2, 2003·JAMA : the Journal of the American Medical Association·Matthias KarstUdo Schneider
Jul 20, 2004·BMJ : British Medical Journal·Geoff Watts
Dec 18, 2004·Cancer Research·Kasem NithipatikomWilliam B Campbell
Mar 9, 2005·Cancer Research·Sami SarfarazHasan Mukhtar
May 3, 2005·The Journal of Clinical Investigation·Douglas Osei-HyiamanGeorge Kunos
Nov 25, 2005·Endocrine Reviews·Uberto PagottoRenato Pasquali
Dec 14, 2005·Experimental Cell Research·Claudia GrimaldiMaurizio Bifulco
Feb 14, 2006·Brain Research·Jian-Ping GongGeorge R Uhl
Mar 30, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·R G Pertwee
May 27, 2006·The Journal of Pharmacology and Experimental Therapeutics·Alessia LigrestiVincenzo Di Marzo
Oct 27, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Cristina BlázquezManuel Guzmán
Jan 17, 2007·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M CôtéV Di Marzo
Oct 19, 2007·International Journal of Cancer. Journal International Du Cancer·Christoph W MichalskiJörg Kleeff
Oct 24, 2007·Molecular Neurobiology·Guillermo VelascoManuel Guzmán
Jan 18, 2008·Cancer Research·Sami SarfarazHasan Mukhtar
Feb 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alberto Ocaña, Atanasio Pandiella
May 9, 2008·Journal of Neuroendocrinology·K Mackie
Jun 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jürg GertschAndreas Zimmer
Aug 9, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ronald J EllisJ Hampton Atkinson
Oct 31, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Iryna A KhasabovaVirginia S Seybold

❮ Previous
Next ❯

Citations

Aug 25, 2016·Drug Discovery Today·Oier Aizpurua-OlaizolaAresatz Usobiaga
Sep 7, 2016·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Jay S KirkwoodJessica E Prenni
Oct 21, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jianfeng WangJin Zhang
Oct 30, 2016·Pharmacology & Therapeutics·Roopesh Singh GangwarFrancesca Levi-Schaffer
Oct 31, 2018·Drugs·Ana Isabel Fraguas-Sánchez, Ana Isabel Torres-Suárez
Oct 11, 2019·The Journal of Dermatological Treatment·Tabrez SheriffHooman Khorasani
Aug 9, 2019·The Journal of Clinical Endocrinology and Metabolism·Joel Ehrenkranz, Michael A Levine
Jul 7, 2017·Nursing·Maria Pettinato
Apr 27, 2019·Frontiers in Pharmacology·Estefanía MorenoEnric Canela
Jan 16, 2021·BMC Complementary Medicine and Therapies·Fatemeh HosamiMasoumeh Tavakoli-Yaraki
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ishtiaq AhmedQingyou Liu
Jul 16, 2021·Pharmacological Reports : PR·Paweł MarzędaJarogniew J Łuszczki
Aug 8, 2021·International Journal of Molecular Sciences·Rodrigo TeodoroRareş-Petru Moldovan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Pharmacology & Therapeutics
Andreas Goutopoulos, A Makriyannis
Current Opinion in Investigational Drugs
Daniele Piomelli
© 2022 Meta ULC. All rights reserved